Edgewise Therapeutics Inc. Common Stock vs Extra Space Storage, Inc. — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.04 (market cap $3.94B), while Extra Space Storage, Inc. trades at $133.62 (market cap $28.26B). The key difference: Extra Space Storage, Inc. is far larger — about 7.2× Edgewise Therapeutics Inc. Common Stock's market cap, and Extra Space Storage, Inc. pays a 4.85% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Extra Space Storage, Inc. for 109 Days on average.
| EWTX | EXR | |
|---|---|---|
Market Cap | $3.94B | $28.26B |
Volume | 810,104 | 1,443,466 |
Sector | Health | Real Estate |
52-Week High | $48.35 | $152.85 |
52-Week Low | $14.89 | $126.67 |
Typical Hold Time | 0 Days | 109 Days |
Enterprise Value | $3.48B | $41.97B |
Dividend Yield | — | 4.85% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Extra Space Storage (EXR) trades at $134.06, up slightly by 0.01% today, with a neutral technical signal and bearish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected soon. Revenue grew to $3.38 billion in 2025, and net income reached $974 million, supported by a robust gross margin of 70.78%. Analyst consensus is evenly split between Buy and Hold, with a price target of $158.33, suggesting potential upside. Recent news highlights leadership transitions and steady dividend payments.
Outlook: EXR shows solid operational performance and financial flexibility, but faces risks from high leverage and softer housing demand. The stock's valuation metrics like P/E of 29.52 and EV/EBITDA of 17.35 indicate premium pricing. Investment opportunity lies in sustained earnings growth and dividend yield, while risks include interest rate sensitivity and competitive pressures in the REIT sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →